Aarti Pharmalabs per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹28.31₹19.27₹30.06₹23.93₹21.35
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹28.29₹19.25₹30.04₹23.93₹21.35
₹234.35₹234.35₹219.55₹193.88₹171.97
₹238.39₹200.69₹233.36₹204.42₹214.64
—₹28.89₹36.58₹23.87₹29.02
−₹16.26−₹16.26−₹7.78₹1.94₹15.82
—₹4.00₹3.50₹2.00₹0.00
9.19.19.19.19.1
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AARTIPHARM₹823.65

Aarti Pharmalabs Ltd.

· Pharma & Health
₹ CrorePeersAARTIDRUGSADVENZYMESAGARWALEYEAKUMSALIVUSAPLLTDCORONAHCGMcap ₹7,467 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS21.3523.9330.0619.2728.31
Diluted EPS21.3523.9330.0419.2528.29
Book Value per Share171.97193.88219.55234.35234.35
Revenue per Share214.64204.42233.36200.69238.39
Cash Flow per Share29.0223.8736.5828.89—
Free Cash Flow per Share15.821.94-7.78-16.26-16.26
Dividends per Share0.002.003.504.00—
Shares Outstanding (cr)9.19.19.19.19.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.